Get the Stockscreener App
2.19
2.34%
0.05
Pre-market:
2.18
-0.010
-0.46%
Pmgc Holdings Inc stock is traded at $2.19, with a volume of 181.08K.
It is up +2.34% in the last 24 hours and down -7.98% over the past month.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
See More
Previous Close:
$2.14
Open:
$2.08
24h Volume:
181.08K
Relative Volume:
0.18
Market Cap:
$3.04M
Revenue:
$2.45M
Net Income/Loss:
$-5.47M
P/E Ratio:
-0.037
EPS:
-59.1634
Net Cash Flow:
$-6.05M
1W Performance:
-0.90%
1M Performance:
-7.98%
6M Performance:
-12.05%
1Y Performance:
-98.24%
1-Day Range:
$2.05
$2.2199
1-Week Range:
$1.96
$3.12
52-Week Range:
$0.6273
$128.00
Pmgc Holdings Inc Stock (ELAB) Company Profile
Name
Pmgc Holdings Inc
Sector
Industry
Phone
888-445-4886
Address
120 NEWPORT CENTER DRIVE, NEWPORT BEACH
Compare ELAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAB
Pmgc Holdings Inc
|
2.19 | 3.04M | 2.45M | -5.47M | -6.05M | -59.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.44 | 114.49B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
518.60 | 52.36B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
298.58 | 39.81B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
574.96 | 35.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
262.41 | 27.94B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmgc Holdings Inc Stock (ELAB) Latest News
PMGC Holdings Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company - I-Connect007
PMGC Holdings to acquire U.S. electronics manufacturer By Investing.com - Investing.com South Africa
PMGC Plans to Acquire US-based Electronics Manufacturing Firm; Shares Rise - marketscreener.com
PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure By Stocktwits - Investing.com India
PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure - Asianet Newsable
PMGC Holdings to acquire U.S. electronics manufacturer - Investing.com Australia
PMGC signs LOI to acquire electronics contract manufacturing company - TipRanks
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company - GlobeNewswire
PMGC Holdings Expands PCB Manufacturing Empire with Second Strategic Acquisition Since April - Stock Titan
Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline By Investing.com - Investing.com South Africa
Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline - Investing.com Australia
Northstrive Biosciences completes phase I research on muscle-wasting treatment - Investing.com
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia - GlobeNewswire
Northstrive Biosciences Amends License Agreement with MOA Life - TipRanks
PMGC Holdings Inc. Files Quarterly Report for Q1 2025, Highlights Strategic Growth Initiatives - Nasdaq
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q - The Manila Times
PMGC Holdings Expands into Hot GLP-1 Market While Pursuing Tech Acquisition: Q1 2025 Details Released - Stock Titan
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market - ADVFN
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire
PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan
PMGC Holdings inks employee secondment deal with Northstrive By Investing.com - Investing.com Nigeria
PMGC Holdings inks employee secondment deal with Northstrive - Investing.com
Northstrive Biosciences Signs Binding Term Sheet with - GlobeNewswire
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22 - Stock Titan
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance - ADVFN
PMGC Holdings Inc: Navigating Market Fluctuations with a 2.72M Market Cap - investchronicle.com
ELAB’s price-to-free cash flow ratio: How it affects investment decisions - uspostnews.com
PMGC Holdings (ELAB) Continues Uptrend During Pre-Hours On Positive Sentiment - Stocks Telegraph
ELAB Stock Price and Chart — NASDAQ:ELAB - TradingView
RESENDNorthstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - GlobeNewswire
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - The Manila Times
Northstrive Biosciences Strengthens IP Portfolio with New - GlobeNewswire
Northstrive Expands Patent Portfolio: New GLP-1 Combo Treatment Could Prevent Muscle Loss in Obesity - Stock Titan
Northstrive Biosciences files patents for obesity treatments By Investing.com - Investing.com Nigeria
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial - The Manila Times
Northstrive Biosciences Co-Founder Featured on Bear Bull - GlobeNewswire
Elevai Labs stock plunges to 52-week low of $2.22 amid steep decline - Investing.com India
Ratios Reveal: Breaking Down PMGC Holdings Inc (ELAB)’s Financial Health - DWinneX
ELAB’s Stock Journey: What Investors Need to Know About PMGC Holdings Inc’s Performance - investchronicle.com
Elevai Labs stock plunges to 52-week low of $2.22 amid steep decline By Investing.com - Investing.com South Africa
What is ELAB’s price-to-sales ratio telling us about the company’s value? - uspostnews.com
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment - GlobeNewswire
Key deals this week: Vista Energy, PMGC Holdings, Colliers, John Wood and more - Seeking Alpha
PMGC Signs Letter of Intent to Purchase Custom IT Packaging Firm; Shares Fall - marketscreener.com
ELAB stock touches 52-week low at $2.51 amid steep annual decline - Investing.com
PMGC signs letter of intent to acquire U.S.-based custom IT packaging company - TipRanks
Pmgc Holdings Signs Letter Of Intent To Acquire Profitable U.S.-Based Custom It Packaging Company - MarketScreener
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company - GlobeNewswire
Strategic Acquisition: PMGC Eyes IT Packaging Leader Serving Major Data Centers - Stock Titan
PMGC’s Northstrive Biosciences signs partnership with Yuva Biosciences - TipRanks
Pmgc Holdings Inc Stock (ELAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.92%
7.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):